Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Duke University Medical Center

Duke University Medical Center in Durham, North Carolina, United States is listed as a site for 2,979 registered clinical trials, 590 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,979
Ongoing 590

This page covers the site record Duke University Medical Center in Durham, North Carolina, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Duke University Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,979 trials counted.

  • Phase 1 280 trials
  • Phase 1/2 147 trials
  • Phase 2 677 trials
  • Phase 2/3 79 trials
  • Phase 3 675 trials
  • Phase 4 134 trials
  • Not applicable 585 trials
  • Observational 387 trials
  • Expanded access 14 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 594 trials
  • Completed 1,830 trials
  • Terminated 491 trials
  • Other 64 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 198

1991: 1 trials (Phase 2 1) 1993: 1 trials (Observational 1) 1995: 2 trials (Observational 1, Phase 3 1) 1996: 1 trials (Observational 1) 1997: 2 trials (Phase 1/2 1, Phase 1 1) 1998: 3 trials (Observational 1, Not applicable 1, Phase 3 1) 1999: 8 trials (Observational 1, Not applicable 3, Phase 3 1, Phase 2/3 1, Phase 2 2) 2000: 22 trials (Observational 2, Not applicable 5, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 3) 2001: 22 trials (Observational 1, Not applicable 5, Phase 4 2, Phase 3 8, Phase 2 4, Phase 1 2) 2002: 30 trials (Observational 3, Not applicable 3, Phase 4 1, Phase 3 12, Phase 2/3 4, Phase 2 5, Phase 1 2) 2003: 54 trials (Observational 5, Not applicable 7, Phase 4 3, Phase 3 15, Phase 2/3 1, Phase 2 14, Phase 1/2 3, Phase 1 6) 2004: 66 trials (Observational 7, Not applicable 7, Phase 4 5, Phase 3 18, Phase 2/3 3, Phase 2 21, Phase 1 5) 2005: 92 trials (Observational 12, Not applicable 13, Phase 4 5, Phase 3 25, Phase 2/3 8, Phase 2 18, Phase 1/2 5, Phase 1 6) 2006: 107 trials (Observational 17, Not applicable 11, Phase 4 10, Phase 3 27, Phase 2/3 4, Phase 2 26, Phase 1/2 6, Phase 1 6) 2007: 129 trials (Other 1, Observational 14, Not applicable 14, Phase 4 7, Phase 3 37, Phase 2/3 2, Phase 2 35, Phase 1/2 7, Phase 1 12) 2008: 129 trials (Observational 14, Not applicable 23, Phase 4 12, Phase 3 33, Phase 2 25, Phase 1/2 7, Phase 1 15) 2009: 148 trials (Observational 21, Not applicable 21, Phase 4 8, Phase 3 38, Phase 2 31, Phase 1/2 7, Phase 1 22) 2010: 130 trials (Observational 18, Not applicable 14, Phase 4 9, Phase 3 30, Phase 2/3 1, Phase 2 35, Phase 1/2 6, Phase 1 17) 2011: 110 trials (Observational 19, Not applicable 17, Phase 4 4, Phase 3 21, Phase 2/3 1, Phase 2 33, Phase 1/2 6, Phase 1 9) 2012: 146 trials (Observational 24, Not applicable 32, Phase 4 6, Phase 3 32, Phase 2 28, Phase 1/2 10, Phase 1 14) 2013: 122 trials (Observational 20, Not applicable 27, Phase 4 4, Phase 3 17, Phase 2/3 4, Phase 2 26, Phase 1/2 8, Phase 1 16) 2014: 144 trials (Observational 23, Not applicable 41, Phase 4 3, Phase 3 21, Phase 2/3 8, Phase 2 28, Phase 1/2 7, Phase 1 13) 2015: 147 trials (Observational 27, Not applicable 32, Phase 4 5, Phase 3 35, Phase 2/3 1, Phase 2 28, Phase 1/2 6, Phase 1 13) 2016: 150 trials (Observational 29, Not applicable 37, Phase 4 7, Phase 3 22, Phase 2/3 2, Phase 2 34, Phase 1/2 5, Phase 1 14) 2017: 198 trials (Observational 21, Not applicable 46, Phase 4 11, Phase 3 36, Phase 2/3 4, Phase 2 56, Phase 1/2 8, Phase 1 16) 2018: 139 trials (Observational 12, Not applicable 30, Phase 4 5, Phase 3 30, Phase 2/3 3, Phase 2 34, Phase 1/2 9, Phase 1 16) 2019: 150 trials (Observational 19, Not applicable 31, Phase 4 5, Phase 3 34, Phase 2/3 8, Phase 2 29, Phase 1/2 8, Phase 1 16) 2020: 131 trials (Observational 13, Not applicable 25, Phase 4 2, Phase 3 31, Phase 2/3 2, Phase 2 39, Phase 1/2 4, Phase 1 15) 2021: 136 trials (Observational 21, Not applicable 42, Phase 4 2, Phase 3 28, Phase 2/3 2, Phase 2 20, Phase 1/2 7, Phase 1 14) 2022: 106 trials (Observational 11, Not applicable 25, Phase 4 2, Phase 3 24, Phase 2/3 9, Phase 2 17, Phase 1/2 12, Phase 1 6) 2023: 91 trials (Observational 8, Not applicable 23, Phase 4 3, Phase 3 23, Phase 2/3 3, Phase 2 27, Phase 1/2 3, Phase 1 1) 2024: 82 trials (Observational 11, Not applicable 13, Phase 4 3, Phase 3 19, Phase 2/3 2, Phase 2 25, Phase 1/2 3, Phase 1 6) 2025: 77 trials (Observational 5, Not applicable 11, Phase 4 5, Phase 3 25, Phase 2/3 1, Phase 2 19, Phase 1/2 4, Phase 1 7)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 68
2025 77
2024 82
2023 91
2022 106
2021 136
2020 131
2019 150
2018 139
2017 198

2026 is partial: trials registered with a 2026 start date so far, not a full year. 5 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.